VIVEbiotech will be participating in Advanced Therapies Week 2026
The company will attend as a Bronze Sponsor and present its capabilities in lentiviral vector development and manufacturing.
VIVEbiotech confirms its participation in Phacilitate’s Advanced Therapies Week 2026, which will take place from February 9 to 12, 2026, at the San Diego Convention Center. The event is recognized as one of the leading international forums for the advanced therapies sector, bringing together industry leaders, researchers, and innovators shaping the future of cell and gene therapies.
As Bronze Sponsors, VIVEbiotech will be present at Booth #638, where the team will showcase the company’s expertise in lentiviral vector development and GMP manufacturing.
Additionally, VIVEbiotech will deliver a Company Presentation in the Innovation Zone on February 10 at 1:30 PM, providing insights into the company’s capabilities, progress, and commitment to driving innovation in the advanced therapies landscape.
VIVEbiotech will be represented by:
• Natalia Elizalde, Chief Business Development Officer
• Victor Polo, Business Development Manager
They are available to arrange meetings through:
🔹 Grip, the event’s partnering platform: https://matchmaking.grip.events/advancedtherapiesweek26/event-login
Natalia and Víctor will participate in networking activities such as Sip & Connect and the Petco Park Takeover.
The company looks forward to engaging with partners, establishing new collaborations, and contributing to key discussions that will shape the future of advanced therapies.
Click here to watch the video message from Natalia Elizalde and Victor Polo about our participation in Advanced Therapies Week 2026.